Jean-Marc Parant
Corporate Officer/Principal at Ipsen Pharma SAS
Network origin in Jean-Marc Parant first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Marc Parant via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| IPSEN | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Human Resources Officer Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
Ipsen Manufacturing Ireland Ltd.
 Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University College Dublin | College/University | Doctorate Degree | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Ipsen OOO | Chairman | ||
| ESSEC Business School | College/University | Masters Business Admin | |
| G5 Santé | Director/Board Member | ||
| European Federation of Pharmaceutical Industries & Assoc | Miscellaneous Commercial Services | Director/Board Member | |
| University of St. Gallen | College/University | Masters Business Admin | |
| GAVI Alliance | Investment Trusts/Mutual Funds | Director/Board Member | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SANOFI | Biotechnology | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| Sciences Po | College/University | Undergraduate Degree | |
Veolia Water Technologies SASU
 Veolia Water Technologies SASU Water UtilitiesUtilities Veolia Water Technologies SAS provides water treatment solutions. It designs, builds, maintains, and upgrades water and wastewater treatment facilities for industrial clients and public authorities. The company is headquartered in Saint-Maurice, France. | Water Utilities | Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Director/Board Member | |
| Scandinavian International Management Institute | College/University | Masters Business Admin | |
| VIVENDI SE | Media Conglomerates | Comptroller/Controller/Auditor | |
| LAGARDÈRE S.A. | Discount Stores | Comptroller/Controller/Auditor | |
Enedis SA
 Enedis SA Electric UtilitiesUtilities Enedis SA manages the public electricity distribution network. Its services include commissioning, repair, meter reading, and contract termination. The company was founded in 2008 and is headquartered in Paris, France. | Electric Utilities | Director of Finance/CFO | |
AW-WS Group Ltd.
 AW-WS Group Ltd. Pulp & PaperProcess Industries AW-WS Group Ltd. manufactures paper and paperboards. It offers carbonless papers used for facsimile paper, forms, and credit card receipts; thermal papers; fine papers; and specialty papers, such as art and tracing papers. The company was founded in 1919 and is headquartered in Basingstoke, the United Kingdom. | Pulp & Paper | Director/Board Member | |
ArjoWiggins SAS
 ArjoWiggins SAS Pulp & PaperProcess Industries ArjoWiggins SAS manufactures and distributes paper. The company was founded in 1991 and is headquartered in Boulogne-Billancourt, France. | Pulp & Paper | Director of Finance/CFO | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chief Operating Officer | |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Biotechnology | Director/Board Member | |
Beaufour Ipsen Industrie SAS
 Beaufour Ipsen Industrie SAS Medical DistributorsDistribution Services Beaufour Ipsen Industrie SAS manufactures pharmaceutical products. The company was founded on July 22, 1942 and is headquartered in Dreux, France. | Medical Distributors | Chairman | |
Ipsen Biopharm Ltd.
 Ipsen Biopharm Ltd. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Ipsen Biopharm Ltd. is a British biopharmaceutical company that aims to prolong patients' lives, improve health outcomes, and create a positive impact for patients and society. Founded in 1982, the company is based in Wrexham, UK. Ipsen specializes in the fields of oncology, neuroscience, and rare disease, and creates and manufactures pharmaceutical products to improve patients' lives through research and innovation. | Pharmaceuticals: Major | Director/Board Member | |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EM Lyon Business School | College/University | Graduate Degree |
Statistics
International
| France | 17 |
| Ireland | 4 |
| United States | 4 |
| Switzerland | 4 |
| United Kingdom | 3 |
Sectoral
| Health Technology | 13 |
| Consumer Services | 10 |
| Utilities | 3 |
| Process Industries | 3 |
| Commercial Services | 2 |
Operational
| Corporate Officer/Principal | 16 |
| Director/Board Member | 11 |
| Chief Executive Officer | 5 |
| Masters Business Admin | 4 |
| Undergraduate Degree | 4 |
Most connected contacts
| Insiders | |
|---|---|
| Aymeric Le Chatelier | 11 |
| Eric Drapé | 10 |
| David Loew | 9 |
| Etienne de Blois | 4 |
| Benoit Hennion | 4 |
| Finbar Larkin | 4 |
| Laetitia Ducroquet | 3 |
| Bartosz Bednarz | 1 |
- Stock Market
- Insiders
- Jean-Marc Parant
- Company connections
